Efficacy of nutritional supplement (Haras) on carbon monoxide levels in smokers and non-smokers: An observational study
Carbon monoxide (CO) concentrations in exhaled air may impart a quick, non-invasive method to determine smoking status. Haras is a nutraceutical medication, which is slowly gaining recognition for its antioxidant and anti-inflammatory activities. The effectiveness of the Haras therapy in smokers and...
Gespeichert in:
Veröffentlicht in: | Journal of oral and maxillofacial pathology : JOMFP 2024, Vol.28 (1), p.23-28 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 28 |
---|---|
container_issue | 1 |
container_start_page | 23 |
container_title | Journal of oral and maxillofacial pathology : JOMFP |
container_volume | 28 |
creator | Chandavarkar, Vidyadevi Mishra, Mithilesh Narayan Bhargava, Deepak Rajashekaraiah, Premalatha Bidadi Singh, Shafali Kanuru, Vijay |
description | Carbon monoxide (CO) concentrations in exhaled air may impart a quick, non-invasive method to determine smoking status. Haras is a nutraceutical medication, which is slowly gaining recognition for its antioxidant and anti-inflammatory activities.
The effectiveness of the Haras therapy in smokers and non-smokers will be assessed by evaluating breath CO levels.
The study included 101 test subjects with 76 subjects of smokers and 25 subjects of non-smokers. Both the test groups were given 10 mL of Haras juice in divided doses per day for 30 days. The CO levels were evaluated using a breath analyser before drug trial and then on the 8
, 15
, 22
and after the conclusion of the drug trial.
The Wilcoxon signed-rank test was used to compare the CO and carboxyhemoglobin levels among smokers and non-smokers.
Smokers had higher mean percent carboxyhemoglobin and mean parts per million CO values than non-smokers, and the difference between the two was shown to be statistically significant (
< 0.001). It was also found to be statistically significant from the first day to the eighth day, the first day to the 15
day, the first day to the 20
second day, first day to the 30
day (
< 0.001).
Haras can be used effectively as an alternative supportive treatment for the diminution of CO levels in smokers and non-smokers. |
doi_str_mv | 10.4103/jomfp.jomfp_420_23 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3060746587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A815581317</galeid><sourcerecordid>A815581317</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3363-2a915e36170b3d7e9f8fb4500d5bcfc1acb4893b569a0c0d4a3213d7ed1ab9ad3</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhi0EokvhD3BAlriUQxZP7CQ2t1VV2kqVuIDUm-VP5CWxg5207L8ny275EkIjzcjW8868hxehl0DWDAh9u02DH9c_umQ1kTV9hFYgBK-ooLeP0YqIjlakFrcn6FkpW0Iazpr6KTqhnBPCar5C9xfeB6PMDieP4zzlMIUUVY_LPI69G1yc8NmVyqq8wSlio7JexpBi-hasw727c33BIeIypC8uF6yixTHF6vh-hzcRJ11cvlMPm6fZ7p6jJ171xb04zlP06f3Fx_Or6ubD5fX55qYylLa0qpWAxtEWOqKp7Zzw3GvWEGIbbbwBZTTjguqmFYoYYpmiNexBC0oLZekpOjvsHXP6OrsyySEU4_peRZfmIilpScfahncL-vovdJvmvDheKGCsA4DF0n8pANaxGsQv6rPqnQzRpykrsz8tNxyahgOF_cX1P6ilrBuCSdH5sPz_IagPApNTKdl5OeYwqLyTQOQ-E_KQht8zsYheHR3PenD2p-QhBPQ7ooa01w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3111474219</pqid></control><display><type>article</type><title>Efficacy of nutritional supplement (Haras) on carbon monoxide levels in smokers and non-smokers: An observational study</title><source>Medknow Open Access Medical Journals(OpenAccess)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Chandavarkar, Vidyadevi ; Mishra, Mithilesh Narayan ; Bhargava, Deepak ; Rajashekaraiah, Premalatha Bidadi ; Singh, Shafali ; Kanuru, Vijay</creator><creatorcontrib>Chandavarkar, Vidyadevi ; Mishra, Mithilesh Narayan ; Bhargava, Deepak ; Rajashekaraiah, Premalatha Bidadi ; Singh, Shafali ; Kanuru, Vijay</creatorcontrib><description>Carbon monoxide (CO) concentrations in exhaled air may impart a quick, non-invasive method to determine smoking status. Haras is a nutraceutical medication, which is slowly gaining recognition for its antioxidant and anti-inflammatory activities.
The effectiveness of the Haras therapy in smokers and non-smokers will be assessed by evaluating breath CO levels.
The study included 101 test subjects with 76 subjects of smokers and 25 subjects of non-smokers. Both the test groups were given 10 mL of Haras juice in divided doses per day for 30 days. The CO levels were evaluated using a breath analyser before drug trial and then on the 8
, 15
, 22
and after the conclusion of the drug trial.
The Wilcoxon signed-rank test was used to compare the CO and carboxyhemoglobin levels among smokers and non-smokers.
Smokers had higher mean percent carboxyhemoglobin and mean parts per million CO values than non-smokers, and the difference between the two was shown to be statistically significant (
< 0.001). It was also found to be statistically significant from the first day to the eighth day, the first day to the 15
day, the first day to the 20
second day, first day to the 30
day (
< 0.001).
Haras can be used effectively as an alternative supportive treatment for the diminution of CO levels in smokers and non-smokers.</description><identifier>ISSN: 0973-029X</identifier><identifier>EISSN: 1998-393X</identifier><identifier>DOI: 10.4103/jomfp.jomfp_420_23</identifier><identifier>PMID: 38800428</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Carbon monoxide ; Carboxyhemoglobin ; Dietary supplements ; Functional foods ; Rankings ; Smokers ; Statistical analysis ; Type 2 diabetes</subject><ispartof>Journal of oral and maxillofacial pathology : JOMFP, 2024, Vol.28 (1), p.23-28</ispartof><rights>Copyright: © 2024 Journal of Oral and Maxillofacial Pathology.</rights><rights>COPYRIGHT 2024 Medknow Publications and Media Pvt. Ltd.</rights><rights>2024. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3363-2a915e36170b3d7e9f8fb4500d5bcfc1acb4893b569a0c0d4a3213d7ed1ab9ad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38800428$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chandavarkar, Vidyadevi</creatorcontrib><creatorcontrib>Mishra, Mithilesh Narayan</creatorcontrib><creatorcontrib>Bhargava, Deepak</creatorcontrib><creatorcontrib>Rajashekaraiah, Premalatha Bidadi</creatorcontrib><creatorcontrib>Singh, Shafali</creatorcontrib><creatorcontrib>Kanuru, Vijay</creatorcontrib><title>Efficacy of nutritional supplement (Haras) on carbon monoxide levels in smokers and non-smokers: An observational study</title><title>Journal of oral and maxillofacial pathology : JOMFP</title><addtitle>J Oral Maxillofac Pathol</addtitle><description>Carbon monoxide (CO) concentrations in exhaled air may impart a quick, non-invasive method to determine smoking status. Haras is a nutraceutical medication, which is slowly gaining recognition for its antioxidant and anti-inflammatory activities.
The effectiveness of the Haras therapy in smokers and non-smokers will be assessed by evaluating breath CO levels.
The study included 101 test subjects with 76 subjects of smokers and 25 subjects of non-smokers. Both the test groups were given 10 mL of Haras juice in divided doses per day for 30 days. The CO levels were evaluated using a breath analyser before drug trial and then on the 8
, 15
, 22
and after the conclusion of the drug trial.
The Wilcoxon signed-rank test was used to compare the CO and carboxyhemoglobin levels among smokers and non-smokers.
Smokers had higher mean percent carboxyhemoglobin and mean parts per million CO values than non-smokers, and the difference between the two was shown to be statistically significant (
< 0.001). It was also found to be statistically significant from the first day to the eighth day, the first day to the 15
day, the first day to the 20
second day, first day to the 30
day (
< 0.001).
Haras can be used effectively as an alternative supportive treatment for the diminution of CO levels in smokers and non-smokers.</description><subject>Carbon monoxide</subject><subject>Carboxyhemoglobin</subject><subject>Dietary supplements</subject><subject>Functional foods</subject><subject>Rankings</subject><subject>Smokers</subject><subject>Statistical analysis</subject><subject>Type 2 diabetes</subject><issn>0973-029X</issn><issn>1998-393X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kk1v1DAQhi0EokvhD3BAlriUQxZP7CQ2t1VV2kqVuIDUm-VP5CWxg5207L8ny275EkIjzcjW8868hxehl0DWDAh9u02DH9c_umQ1kTV9hFYgBK-ooLeP0YqIjlakFrcn6FkpW0Iazpr6KTqhnBPCar5C9xfeB6PMDieP4zzlMIUUVY_LPI69G1yc8NmVyqq8wSlio7JexpBi-hasw727c33BIeIypC8uF6yixTHF6vh-hzcRJ11cvlMPm6fZ7p6jJ171xb04zlP06f3Fx_Or6ubD5fX55qYylLa0qpWAxtEWOqKp7Zzw3GvWEGIbbbwBZTTjguqmFYoYYpmiNexBC0oLZekpOjvsHXP6OrsyySEU4_peRZfmIilpScfahncL-vovdJvmvDheKGCsA4DF0n8pANaxGsQv6rPqnQzRpykrsz8tNxyahgOF_cX1P6ilrBuCSdH5sPz_IagPApNTKdl5OeYwqLyTQOQ-E_KQht8zsYheHR3PenD2p-QhBPQ7ooa01w</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Chandavarkar, Vidyadevi</creator><creator>Mishra, Mithilesh Narayan</creator><creator>Bhargava, Deepak</creator><creator>Rajashekaraiah, Premalatha Bidadi</creator><creator>Singh, Shafali</creator><creator>Kanuru, Vijay</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>2024</creationdate><title>Efficacy of nutritional supplement (Haras) on carbon monoxide levels in smokers and non-smokers: An observational study</title><author>Chandavarkar, Vidyadevi ; Mishra, Mithilesh Narayan ; Bhargava, Deepak ; Rajashekaraiah, Premalatha Bidadi ; Singh, Shafali ; Kanuru, Vijay</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3363-2a915e36170b3d7e9f8fb4500d5bcfc1acb4893b569a0c0d4a3213d7ed1ab9ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Carbon monoxide</topic><topic>Carboxyhemoglobin</topic><topic>Dietary supplements</topic><topic>Functional foods</topic><topic>Rankings</topic><topic>Smokers</topic><topic>Statistical analysis</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chandavarkar, Vidyadevi</creatorcontrib><creatorcontrib>Mishra, Mithilesh Narayan</creatorcontrib><creatorcontrib>Bhargava, Deepak</creatorcontrib><creatorcontrib>Rajashekaraiah, Premalatha Bidadi</creatorcontrib><creatorcontrib>Singh, Shafali</creatorcontrib><creatorcontrib>Kanuru, Vijay</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of oral and maxillofacial pathology : JOMFP</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chandavarkar, Vidyadevi</au><au>Mishra, Mithilesh Narayan</au><au>Bhargava, Deepak</au><au>Rajashekaraiah, Premalatha Bidadi</au><au>Singh, Shafali</au><au>Kanuru, Vijay</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of nutritional supplement (Haras) on carbon monoxide levels in smokers and non-smokers: An observational study</atitle><jtitle>Journal of oral and maxillofacial pathology : JOMFP</jtitle><addtitle>J Oral Maxillofac Pathol</addtitle><date>2024</date><risdate>2024</risdate><volume>28</volume><issue>1</issue><spage>23</spage><epage>28</epage><pages>23-28</pages><issn>0973-029X</issn><eissn>1998-393X</eissn><abstract>Carbon monoxide (CO) concentrations in exhaled air may impart a quick, non-invasive method to determine smoking status. Haras is a nutraceutical medication, which is slowly gaining recognition for its antioxidant and anti-inflammatory activities.
The effectiveness of the Haras therapy in smokers and non-smokers will be assessed by evaluating breath CO levels.
The study included 101 test subjects with 76 subjects of smokers and 25 subjects of non-smokers. Both the test groups were given 10 mL of Haras juice in divided doses per day for 30 days. The CO levels were evaluated using a breath analyser before drug trial and then on the 8
, 15
, 22
and after the conclusion of the drug trial.
The Wilcoxon signed-rank test was used to compare the CO and carboxyhemoglobin levels among smokers and non-smokers.
Smokers had higher mean percent carboxyhemoglobin and mean parts per million CO values than non-smokers, and the difference between the two was shown to be statistically significant (
< 0.001). It was also found to be statistically significant from the first day to the eighth day, the first day to the 15
day, the first day to the 20
second day, first day to the 30
day (
< 0.001).
Haras can be used effectively as an alternative supportive treatment for the diminution of CO levels in smokers and non-smokers.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>38800428</pmid><doi>10.4103/jomfp.jomfp_420_23</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0973-029X |
ispartof | Journal of oral and maxillofacial pathology : JOMFP, 2024, Vol.28 (1), p.23-28 |
issn | 0973-029X 1998-393X |
language | eng |
recordid | cdi_proquest_miscellaneous_3060746587 |
source | Medknow Open Access Medical Journals(OpenAccess); EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access |
subjects | Carbon monoxide Carboxyhemoglobin Dietary supplements Functional foods Rankings Smokers Statistical analysis Type 2 diabetes |
title | Efficacy of nutritional supplement (Haras) on carbon monoxide levels in smokers and non-smokers: An observational study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A36%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20nutritional%20supplement%20(Haras)%20on%20carbon%20monoxide%20levels%20in%20smokers%20and%20non-smokers:%20An%20observational%20study&rft.jtitle=Journal%20of%20oral%20and%20maxillofacial%20pathology%20:%20JOMFP&rft.au=Chandavarkar,%20Vidyadevi&rft.date=2024&rft.volume=28&rft.issue=1&rft.spage=23&rft.epage=28&rft.pages=23-28&rft.issn=0973-029X&rft.eissn=1998-393X&rft_id=info:doi/10.4103/jomfp.jomfp_420_23&rft_dat=%3Cgale_proqu%3EA815581317%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3111474219&rft_id=info:pmid/38800428&rft_galeid=A815581317&rfr_iscdi=true |